Normonatremic Transient Renal Salt Wasting (TRSW) Is Not Rare in a Department of Internal Medicine
Abstract
:1. Introduction
2. Materials and Methods
3. Result
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Musch, W.; Decaux, G. Utility and limitations of biochemical parameters in the evolution of hyponatremia in the elderly. Int. Urol. Nephrol. 2001, 32, 475–793. [Google Scholar] [CrossRef] [PubMed]
- Musch, W.; Decaux, G. Hyponatremia secondary to transient renal salt wasting (TRSW): A not so uncommon observation in the elderly. Clin. Nephrol. 2019, 91, 344–352. [Google Scholar] [CrossRef] [PubMed]
- Peters, J.P. A salt wasting syndrome associated with cerebral disease. Trans. Assoc. Am. Physicians 1950, 63, 57–64. [Google Scholar] [PubMed]
- Golber, M.; Handler, J.S. Hyponatremia and renal wasting of sodium in patients with malfunction of the central nervous system. N. Engl. J. Med. 1960, 263, 1037–1043. [Google Scholar]
- Mangos, J.; Lobeck, C.C. Studies of sustained hyponatremia due to central nervous system infection. Pediatrics 1964, 34, 503–510. [Google Scholar] [CrossRef] [PubMed]
- Maesaka, J.; Imbriano, L.; Mattan, J.; Gallagher, D.; Bade, N.; Sharif, S. Differentiating SIADH from Cerebral/Renal salt wasting: Failure of the volume approach and need for a new approach to hyponatremia. J. Clin. Med. 2014, 3, 1373–1385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Costello-Boerrigter, L.; Boerrigter, G.; Burnett, J.C., Jr. Revisiting salt and water retention: New diuretics, aquaretics and natriuretics. Med. Clin. N. Am. 2003, 87, 475–491. [Google Scholar] [CrossRef] [PubMed]
- Goetz, K.L. Physiology and pathophysiology of atrial peptides. Am. J. Physiol. Endocrinol. Metab. 1988, 254, E1–E5. [Google Scholar] [CrossRef] [PubMed]
- Richards, A.; Tonolo, G.; Montorsi, P.; Finlayson, J.; Fraser, R.; Inglis, G.; Towrie, A.; Morton, J.J. Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man. J. Clin. Endocrinol. Metab. 1988, 66, 465–472. [Google Scholar] [CrossRef] [PubMed]
- Maesaka, J.; Imbriano, L.; Ali, N.; Ilamathi, E. Is it cerebral or renal salt wasting? Kidney. Int. 2009, 76, 934–938. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, C.; Lewicki, J.; Johnson, L.; Cogan, M.C. Renal mechanism of action of rat atrial natriuretic factor. J. Clin. Investig. 1985, 75, 769–773. [Google Scholar] [CrossRef] [PubMed]
Sex/Age | SNa | SK | Urea (mg/dL) | Creat (mg/dL) | Uric (mg/dL) | Ht (%) | Prot (g/dL) | Ca (mg/dL) | PO4 (mg/dL) | UOsm | FE.Na (%) | FE.K (%) | UCa/UCr | UCreat (mg/dL) | FePO4 (%) | FE.Uric (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
♂ 69 | 139 | 4.3 | 39 | 0.9 | 7.3 | 42 | 7.0 | 9.4 | 3.9 | 249 | 2.5 | 32 | 0.165 | 20 | 25.5 | -- | Angina |
♀ 87 | 142 | 3.7 | 41 | 1 | 5.9 | 48.6 | 8.4 | 10 | 3.3 | 290 | 2.2 | 23 | 0.3 | 20 | 30 | 11 | Angina/HBP |
♂ 87 | 141 | 3.6 | 56 | 0.8 | 3.9 | 33.4 | 7.0 | 10.2 | 3.2 | 538 | 4.4 | 21.1 | 0.5 | 21 | 43 | 22.5 | Rectal bleeding HBP |
♀ 67 | 140 | 4.8 | 72 | 0.8 | 6.2 | 47.3 | 8.6 | 10.3 | 3.3 | 455 | 2.8 | 17.5 | 0.35 | 20 | 26.6 | 13 | Syncope/HBP |
♀ 84 | 136 | 4.2 | 23 | 0.6 | -- | 40.1 | -- | 9.2 | 3.6 | 422 | 2.7 | 25 | 0.64 | 21 | 27.5 | -- | Stroke |
♀ 75 | 133 | 4.8 | 51 | 0.9 | 5.4 | 33.1 | 6.6 | 8.7 | -- | 406 | 3.1 | 23 | 0.23 | 19 | -- | 9.2 | Epileptic crisis |
♀ 77 | 140 | 4.1 | 35 | 0.9 | 4.6 | 37.6 | 7.9 | 10.1 | 2.9 | 320 | 2.4 | 35 | 0.30 | 20 | 18.6 | 14.7 | Stroke |
♀ 80 | 138 | 3.6 | 34 | 0.9 | 2.5 | 39.4 | 7.1 | 9.6 | 3.5 | 476 | 3.2 | 27 | 0.36 | 20 | 14 | 23.4 | Angina |
♀ 86 | 137 | 4.1 | 37 | 0.9 | 4.3 | 40.2 | 8.1 | 9.8 | 4.5 | 403 | 2.4 | 30 | 0.5 | 40 | 24 | 14.6 | Transient ischemic attack |
♂ 76 | 138 | 3.7 | 38 | 0.9 | 7.6 | 38.7 | 7.9 | 9.8 | 2.8 | 469 | 3.5 | 35 | 0.28 | 40 | 18 | 11 | Stroke atrial fibrillation |
♂ 68 | 140 | 4 | 34 | 0.7 | 4 | -- | 6.1 | 8.7 | 2.8 | 394 | 2.6 | 39 | 0.43 | 26 | -- | 15.5 | Pneumothorax COPD |
Angina | J0 | J8hr | J24hr | J48hr | J96hr |
---|---|---|---|---|---|
+ | - | - | - | No clinical pain | |
PNa (mEq/L) | 138 | 137 | 139 | 139 | |
PK (mEq/L) | 3.6 | 4.6 | 3.9 | 3.7 | |
PUrea (mg/dL) | 34 | 30 | 35 | 34 | |
PCreat (mg/dL) | 0.9 | 0.8 | 0.8 | 0.8 | |
PUric acid (mg/dL) | 2.5 | 3.2 | 2.7 | 3.2 | |
Haematocrit (%) | 39.4 | 39 | 35.3 | 35 | |
PProtein (g/dL) | 7.1 | 6.9 | 6.2 | 6.5 | |
PCalcium (mg/dL) | 9.6 | 9.6 | 8.5 | 9.1 | |
PPhosphore (mg/dL) | 3.5 | 3.5 | 3.8 | 4.2 | |
FE.Na (%) | 3.2 | 0.59 | 0.57 | 0.31 | 3.6 |
FE.K (%) | 27.3 | 8.8 | 9.9 | 12 | 30 |
FE.Urea (%) | 66 | 57 | 41 | 46 | 67 |
FE.Uric acid (%) | 23.4 | 18 | 9.4 | 14 | 21 |
UCa/UCreat | 0.36 | 0.25 | 0.13 | 0.14 | 0.2 |
Fe.PO4 (%) | 14.4 | 14.8 | 11.4 | 10.7 | 21 |
UCr/PCr | 22 | 44 | 50 | 50 | 25 |
UOsm | 476 | -- | -- | -- | 527 |
ADH (0–7 pg/mL) | 0.6 | ||||
REN (7.5–40 pg/mL) | 2 | ||||
Aldo (0–310 pg/mL) | 52 | ||||
ANP (25–65 ng/L) | 185 |
Controls | TRSW (n = 11) | Under Furosemide (n = 9) | Before Furosemide (n = 5) |
---|---|---|---|
BW (kg) | 63.6 ± 13 | 59.4 ± 11 | NA |
SNa (135–145 mEq/L) | 138 ± 2.4 | 139 ± 3.6 | 138 ± 3 |
SK (3.5–5.1 mEq/L) | 4.1 ± 0.45 | 4.1 ± 0.4 | 4.2 ± 0.3 |
Urea (17–48 mg/dL) | 42 ± 12.5 | 46 ± 12 | 36 ± 17 |
Creatinin (0.7–1.1 mg/dL) | 0.85 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 |
FE.Osm (<3%) | 5.1 ± 1.4 | --- | --- |
FE.Na (<1.6%) | 2.9 ± 0.6 | 3.0 ± 0.8 | 0.23 ± 0.2 * |
FE.K (<18%) | 28 ± 6.4 | 22 ± 5.5 | 12.5 ± 5 ** |
UCa/UCr (<0.20) | 0.37 ± 0.13 | 0.35 ± 0.12 | 0.10 ± 0.06 * |
FE.PO4 (N < 20%) | 23.2 ± 9.6 | 18.1 ± 6.2 | 11.5 ± 4.9 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Musch, W.; Decaux, G. Normonatremic Transient Renal Salt Wasting (TRSW) Is Not Rare in a Department of Internal Medicine. J. Clin. Med. 2023, 12, 397. https://doi.org/10.3390/jcm12020397
Musch W, Decaux G. Normonatremic Transient Renal Salt Wasting (TRSW) Is Not Rare in a Department of Internal Medicine. Journal of Clinical Medicine. 2023; 12(2):397. https://doi.org/10.3390/jcm12020397
Chicago/Turabian StyleMusch, Wim, and Guy Decaux. 2023. "Normonatremic Transient Renal Salt Wasting (TRSW) Is Not Rare in a Department of Internal Medicine" Journal of Clinical Medicine 12, no. 2: 397. https://doi.org/10.3390/jcm12020397